Publication: Studies of the neurotoxicity of oral artemisinin derivatives in mice
Issued Date
2000-01-01
Resource Type
ISSN
00029637
Other identifier(s)
2-s2.0-0033770964
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
American Journal of Tropical Medicine and Hygiene. Vol.62, No.3 (2000), 409-412
Suggested Citation
A. Nontprasert, S. Pukrittayakamee, M. Nosten-Bertrand, S. Vanijanonta, N. J. White Studies of the neurotoxicity of oral artemisinin derivatives in mice. American Journal of Tropical Medicine and Hygiene. Vol.62, No.3 (2000), 409-412. doi:10.4269/ajtmh.2000.62.409 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/26002
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Studies of the neurotoxicity of oral artemisinin derivatives in mice
Other Contributor(s)
Abstract
Intramuscular injections of high doses of the oil-soluble antimalarial artemisinin derivatives artemether and arteether produce an unusual pattern of selective damage to brain stem centers in experimental mammals, predominantly those involved in auditory processing and vestibular reflexes. We have shown recently in adult Swiss albino mice that parenteral artesunate, a water, soluble derivative, is significantly less neurotoxic than intramuscular artemether in this murine model. Using the same model, in which the drugs were administered daily for 28 days, the neurotoxic potential of the oral drugs was assessed and compared with the parenteral routes of administration. The dose causing neurotoxicity or death in 50% of animals (ED50), was approximately 300 mg/kg/day of oral artemether and artesunate compared to 50 mg/kg/day of intramuscular artemether. Doses of intramuscular artemether > 100 mg/kg/day were uniformly lethal. When oral artemether was given in peanut oil there was an increase in neurotoxicity and mortality compared with the aqueous suspension (P = 0.002), and when the food pellets were coated with artemether in oil, giving relatively constant oral intake, neurotoxicity was further increased; ED50= 150 mg/kg/day (P = 0.017). These data indicate that once-daily oral administration of artesunate or artemether is relatively safe, presumably because the central nervous system is exposed transiently, whereas constant exposure either from depot intramuscular injection of oil-based drug, or constant oral intake carries relatively greater neurotoxic potential.